| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.
|
Biol Blood Marrow Transplant
|
2008
|
7.10
|
|
2
|
Efficacy of communication skills training for giving bad news and discussing transitions to palliative care.
|
Arch Intern Med
|
2007
|
5.23
|
|
3
|
HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.
|
N Engl J Med
|
2012
|
4.52
|
|
4
|
Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation.
|
Am J Respir Crit Care Med
|
2003
|
2.49
|
|
5
|
Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens.
|
Blood
|
2010
|
2.45
|
|
6
|
MHC haplotype matching for unrelated hematopoietic cell transplantation.
|
PLoS Med
|
2007
|
1.83
|
|
7
|
Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma.
|
Blood
|
2011
|
1.76
|
|
8
|
Mutation at the polymerase active site of mouse DNA polymerase delta increases genomic instability and accelerates tumorigenesis.
|
Mol Cell Biol
|
2007
|
1.74
|
|
9
|
Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia.
|
J Clin Oncol
|
2011
|
1.70
|
|
10
|
Pretransplantation therapy with azacitidine vs induction chemotherapy and posttransplantation outcome in patients with MDS.
|
Biol Blood Marrow Transplant
|
2012
|
1.67
|
|
11
|
The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients.
|
Biol Blood Marrow Transplant
|
2009
|
1.56
|
|
12
|
Frequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remission.
|
J Clin Oncol
|
2013
|
1.41
|
|
13
|
CD33 expression and P-glycoprotein-mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin monotherapy.
|
Blood
|
2007
|
1.40
|
|
14
|
The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation.
|
Blood
|
2012
|
1.35
|
|
15
|
High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma.
|
J Clin Oncol
|
2007
|
1.31
|
|
16
|
Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation.
|
Blood
|
2010
|
1.30
|
|
17
|
Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts.
|
J Clin Invest
|
2015
|
1.13
|
|
18
|
Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantation.
|
Biol Blood Marrow Transplant
|
2011
|
1.11
|
|
19
|
Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbidities.
|
Biol Blood Marrow Transplant
|
2010
|
1.10
|
|
20
|
Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome.
|
Biol Blood Marrow Transplant
|
2006
|
1.08
|
|
21
|
Adjusted estimates for time-to-event endpoints.
|
Lifetime Data Anal
|
2008
|
1.05
|
|
22
|
Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology Consortium.
|
Leuk Lymphoma
|
2010
|
1.02
|
|
23
|
Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia.
|
Blood
|
2005
|
1.01
|
|
24
|
Expression, signaling proficiency, and stimulatory function of the NKG2D lymphocyte receptor in human cancer cells.
|
Proc Natl Acad Sci U S A
|
2011
|
0.99
|
|
25
|
HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk category.
|
Biol Blood Marrow Transplant
|
2010
|
0.97
|
|
26
|
High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experience.
|
Cancer
|
2008
|
0.95
|
|
27
|
Disparity for a newly identified minor histocompatibility antigen, HA-8, correlates with acute graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling.
|
Br J Haematol
|
2003
|
0.95
|
|
28
|
Early CD3 peripheral blood chimerism predicts the long-term engrafting unit following myeloablative double-cord blood transplantation.
|
Biol Blood Marrow Transplant
|
2012
|
0.89
|
|
29
|
Mapping MHC-resident transplantation determinants.
|
Biol Blood Marrow Transplant
|
2007
|
0.89
|
|
30
|
Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest dose.
|
J Nucl Med
|
2008
|
0.86
|
|
31
|
Blood and gastric FOXP3+ T cells are not decreased in human gastric graft-versus-host disease.
|
Biol Blood Marrow Transplant
|
2010
|
0.86
|
|
32
|
Allogeneic hematopoietic cell transplantation with full-intensity conditioning for adult acute lymphoblastic leukemia: results from a single center, 1998-2006.
|
Biol Blood Marrow Transplant
|
2010
|
0.85
|
|
33
|
CCR5 expression on cells from HLA-matched unrelated marrow donors and graft-versus-host disease.
|
Biol Blood Marrow Transplant
|
2009
|
0.84
|
|
34
|
Identification of DJ-1/PARK-7 as a determinant of stroma-dependent and TNF-alpha-induced apoptosis in MDS using mass spectrometry and phosphopeptide analysis.
|
Blood
|
2010
|
0.84
|
|
35
|
A phase I study of pulse high-dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide (ICE) in patients with relapsed lymphoma.
|
Br J Haematol
|
2013
|
0.79
|
|
36
|
The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantation.
|
Leuk Lymphoma
|
2007
|
0.78
|
|
37
|
Pharmacological treatment of obstructive sleep apnea with a combination of pseudoephedrine and domperidone.
|
J Clin Sleep Med
|
2010
|
0.78
|
|
38
|
Donor activating KIR2DS1 in leukemia.
|
N Engl J Med
|
2014
|
0.77
|
|
39
|
Who will manage American patients with diabetes? Residents' career preferences and perceptions of diabetes care.
|
Endocr Pract
|
2011
|
0.77
|
|
40
|
Mitoxantrone for worsening multiple sclerosis: tolerability, toxicity, adherence and efficacy in the clinical setting.
|
Clin Neurol Neurosurg
|
2010
|
0.76
|
|
41
|
Components of the revised International Prognostic Scoring System and outcome after hematopoietic cell transplantation for myelodysplastic syndrome.
|
Blood
|
2013
|
0.75
|
|
42
|
Risk of ruling out severe acute respiratory syndrome by ruling in another diagnosis: variable incidence of atypical bacteria coinfection based on diagnostic assays.
|
Can Respir J
|
2006
|
0.75
|
|
43
|
1,5-ANHYDROGLUCITOL AND NEONATAL COMPLICATIONS IN PREGNANCY COMPLICATED BY DIABETES.
|
Endocr Pract
|
2015
|
0.75
|